Group One Trading, L.P. My Md Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.22 - $0.58 $4,186 - $11,037	-19,031 Reduced 57.89%	13,846 $3,000
Q3 2023 Nov 09, 2023	SELL	$0.47 - $1.87 $1,590 - $6,328	-3,384 Reduced 9.33%	32,877 $19,000
Q2 2023 Aug 09, 2023	BUY	$1.44 - $2.26 $6,557 - $10,292	4,554 Added 14.36%	36,261 $54,000
Q1 2023 May 12, 2023	BUY	$1.1 - $2.86 $27,441 - $71,348	24,947 Added 369.04%	31,707 $54,000
Q4 2022 Feb 09, 2023	BUY	$0.92 - $96.0 $4,441 - $463,488	4,828 Added 249.9%	6,760 $7,000
Q3 2022 Nov 09, 2022	SELL	$2.22 - $82.2 $999 - $36,990	-450 Reduced 18.89%	1,932 $5,000
Q2 2022 Aug 11, 2022	SELL	$2.0 - $4.78 $1,400 - $3,346	-700 Reduced 22.71%	2,382 $5,000
Q1 2022 May 12, 2022	SELL	$3.34 - $6.05 $3,340 - $6,050	-1,000 Reduced 24.5%	3,082 $14,000
Q4 2021 Feb 11, 2022	BUY	$5.46 - $9.69 $20,764 - $36,851	3,803 Added 1363.08%	4,082 $25,000
Q3 2021 Nov 12, 2021	BUY	$4.64 - $7.94 $366 - $627	79 Added 39.5%	279 $2,000
Q2 2021 Aug 10, 2021	BUY	$3.39 - $6.98 $678 - $1,396	200 New	200 $1,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.